Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

NCT00019838

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Refractory Cancer

NCT00019344

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +52 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

NCT00020111

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +30 more
Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

View all 52 locations

View Trial Details

Completed

Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells

NCT00020072

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Depsipeptide in Treating Patients With Solid Tumors

NCT00019318

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

NCT00506922

Conditions: Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)

NCT00771472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Completed

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

NCT01065025

Conditions: Advanced and Incurable Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Universitätsklinikum Essen Essen, Germany

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg (KTB) Freiburg im Breisgau, Germany

View Trial Details

Completed

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

NCT00958256

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas

NCT01555242

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: BC Cancer Agency-Vancouver Centre Vancouver, British Columbia, Canada

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions